Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDCD4 | Q53EL6 | 2/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | PPARG | P37231 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | GRM2 | Q14416 | 10/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16320605 | 1.00 | PDCD4 (0.58) | PDCD4CYP1A2PPARGALDH1A1GRM2 | |
| SCHEMBL16341541 | 1.00 | PDCD4 (0.58) | PDCD4CYP1A2PPARGALDH1A1GRM2 | |
| SCHEMBL16341360 | 1.00 | PDCD4 (0.58) | PDCD4CYP1A2PPARGALDH1A1GRM2 | |
| SCHEMBL16340799 | 1.00 | PDCD4 (0.58) | PDCD4CYP1A2PPARGALDH1A1GRM2 | |
| SCHEMBL16341658 | 1.00 | PDCD4 (0.58) | PDCD4CYP1A2PPARGALDH1A1GRM2 | |
| SCHEMBL4651591 | 1.00 | PDCD4 (0.58) | PDCD4CYP1A2PPARGALDH1A1GRM2 | |
| SCHEMBL16341423 | 1.00 | PDCD4 (0.58) | PDCD4CYP1A2PPARGALDH1A1GRM2 | |
| SCHEMBL16340997 | 1.00 | PDCD4 (0.58) | PDCD4CYP1A2PPARGALDH1A1GRM2 | |
| SCHEMBL3662367 | 1.00 | PDCD4 (0.58) | PDCD4CYP1A2PPARGALDH1A1GRM2 | |
| SCHEMBL31711153 | 1.00 | PDCD4 (0.58) | PDCD4CYP1A2PPARGALDH1A1GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3107904-B1 | SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME | P2 SCIENCE INC (US) | 2019-06-05 | — | — | EP | claimed |
| US-10011582-B2 | Substituted delta-lactones and methods of preparing same | P2 SCIENCE, INC. (US) | 2018-07-03 | — | — | US | claimed |
| US-20170057940-A1 | SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME | P2 SCIENCE, INC. | 2017-03-02 | — | — | US | claimed |
| EP-3107904-A1 | SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME | P2 Science, Inc. (US) | 2016-12-28 | — | — | EP | claimed |
| WO-2015126936-A1 | SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME | P2 SCIENCE, INC. (US) | 2015-08-27 | — | — | WO | claimed |
| EP-3107904-B1 | SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME | P2 SCIENCE INC (US) | 2019-06-05 | — | — | EP | disclosed |
| US-10011582-B2 | Substituted delta-lactones and methods of preparing same | P2 SCIENCE, INC. (US) | 2018-07-03 | — | — | US | disclosed |
| US-20170057940-A1 | SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME | P2 SCIENCE, INC. | 2017-03-02 | — | — | US | disclosed |
| EP-3107904-A1 | SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME | P2 Science, Inc. (US) | 2016-12-28 | — | — | EP | disclosed |
| WO-2015126936-A1 | SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME | P2 SCIENCE, INC. (US) | 2015-08-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10011582-B2 | Substituted delta-lactones and methods of preparing same | FASN, EBP, LSS | PDCD4 3770/4885CYP1A2 302/4885PPARG 79/4885 |
| US-20170057940-A1 | SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME | FASN, EBP, LSS | PDCD4 3770/4885CYP1A2 302/4885PPARG 79/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.